Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Foster

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Journal of the International AIDS Society|July 8, 2021
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort)Margherita Doria, Sonia Zicari, Nicola Cotugno, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
HIV Medicine|December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022Laura Waters, Alan Winston, Iain Reeves, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected ChildrenAlfredo Tagarro, Man Chan, Paola Zangari, et al.
Frontiers in Immunology|April 18, 2022
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive TherapyAlessandra Ruggiero, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
The Lancet. HIV|August 14, 2025
Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshopCatherine J Wedderburn, Ceri Evans, Elaine J Abrams, et al.
Frontiers in Immunology|March 6, 2024
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ARTKathleen Gärtner, Sara Domínguez-Rodríguez, Judith Heaney, et al.
The Lancet. HIV|July 26, 2024
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortiumLouise Kuhn, Shaun Barnabas, Nicola Cotugno, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2024
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma FibrosisSei Muraoka, William D Brodie, Megan N Mattichak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2025
Viral suppression, viral failure and safety outcomes in children and adolescents living with HIV on dolutegravir in Europe and ThailandKaren Scott, John O'Rourke, Charlotte Jackson, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of the International AIDS Society|July 8, 2021
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort)Margherita Doria, Sonia Zicari, Nicola Cotugno, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
HIV Medicine|December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022Laura Waters, Alan Winston, Iain Reeves, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected ChildrenAlfredo Tagarro, Man Chan, Paola Zangari, et al.
Frontiers in Immunology|April 18, 2022
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive TherapyAlessandra Ruggiero, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
The Lancet. HIV|August 14, 2025
Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshopCatherine J Wedderburn, Ceri Evans, Elaine J Abrams, et al.
Frontiers in Immunology|March 6, 2024
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ARTKathleen Gärtner, Sara Domínguez-Rodríguez, Judith Heaney, et al.
The Lancet. HIV|July 26, 2024
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortiumLouise Kuhn, Shaun Barnabas, Nicola Cotugno, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2024
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma FibrosisSei Muraoka, William D Brodie, Megan N Mattichak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2025
Viral suppression, viral failure and safety outcomes in children and adolescents living with HIV on dolutegravir in Europe and ThailandKaren Scott, John O'Rourke, Charlotte Jackson, et al.
Pageof 15